What is the treatment for postpartum hemorrhage (PPH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Postpartum Hemorrhage (PPH)

Early administration of intravenous tranexamic acid (within 3 hours of birth) at a fixed dose of 1g over 10 minutes, with a second dose if bleeding continues after 30 minutes, is strongly recommended for all cases of PPH regardless of cause, in addition to standard care including oxytocin. 1, 2

First-Line Management

  1. Immediate assessment and diagnosis

    • PPH is defined as blood loss >500 mL after vaginal delivery or >1000 mL after cesarean section 2
    • Use the "Four T's" approach to identify the cause:
      • Tone (uterine atony, 70-80% of cases)
      • Trauma (genital tract trauma)
      • Tissue (retained placental tissue)
      • Thrombin (coagulopathies) 2, 3
  2. Initial pharmacological management

    • Oxytocin: First-line uterotonic
      • 5-10 IU slow IV/IM injection followed by maintenance infusion
      • Total cumulative dose should not exceed 40 IU 2, 4, 5
    • Manual uterine massage and bimanual compression 5, 3
    • Tranexamic acid (TXA): 1g IV over 10 minutes within 3 hours of birth
      • Second dose of 1g if bleeding continues after 30 minutes or restarts within 24 hours
      • Efficacy decreases by 10% for every 15-minute delay 1, 2

Second-Line Management

If bleeding persists after oxytocin and TXA:

  1. Second-line uterotonics

    • Sulprostone (prostaglandin E2 analog): Should be administered within 30 minutes of PPH diagnosis if oxytocin fails 5
    • Carboprost tromethamine (prostaglandin F2α analog):
      • 250 μg IM, may repeat at 15-90 minute intervals
      • Maximum total dose: 2 mg (8 doses) 6
  2. Mechanical interventions

    • Intrauterine balloon tamponade if pharmacological management fails and before surgical interventions 2, 5

Advanced Interventions

If bleeding continues despite above measures:

  1. Fluid resuscitation and blood product management

    • Maintain hemoglobin >8 g/dL 2, 5
    • Maintain fibrinogen levels ≥2 g/L 5
    • Administer crystalloids for initial volume replacement 2
    • Consider fresh frozen plasma after 4 units of packed red blood cells 2
    • Prevent and treat hypothermia by warming infusion solutions and blood products 2, 5
    • Administer oxygen in cases of severe PPH 2, 5
  2. Invasive procedures

    • Arterial embolization if patient is hemodynamically stable and facilities available 2, 5, 7
    • Surgical interventions if other measures fail:
      • Uterine compression sutures
      • Uterine or internal iliac artery ligation
      • Hysterectomy as last resort 2, 3

Important Considerations

  1. Timing is critical

    • TXA must be given within 3 hours of birth; after this timeframe, it may be harmful 1, 2
    • If pharmacological treatments fail to control bleeding within 30 minutes, proceed to invasive treatments 5, 7
  2. Team-based approach

    • Multidisciplinary team including obstetricians, anesthesiologists, and blood bank personnel 7, 3
    • Clear communication and predefined protocols improve outcomes 3, 8
  3. Monitoring

    • Continuous assessment of vital signs and blood loss
    • Point-of-care testing for coagulation status when available 2
  4. Prevention

    • Active management of the third stage of labor is recommended for all deliveries
    • Prophylactic oxytocin after delivery of the anterior shoulder 2, 9

Common Pitfalls to Avoid

  • Delaying TXA administration beyond 3 hours after birth
  • Failing to escalate treatment promptly if first-line measures are ineffective
  • Underestimating blood loss (consider using collection bags for accurate measurement)
  • Not identifying and addressing the specific cause of PPH while simultaneously treating

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Postpartum Hemorrhage Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Postpartum Hemorrhage: A Comprehensive Review of Guidelines.

Obstetrical & gynecological survey, 2022

Research

[Anesthesic practices in patients with severe postpartum hemorrhage with persistent or worsening bleeding].

Journal de gynecologie, obstetrique et biologie de la reproduction, 2004

Research

Recognition and Management of Postpartum Hemorrhage.

Maternal-fetal medicine (Wolters Kluwer Health, Inc.), 2025

Research

Postpartum Hemorrhage: Prevention and Treatment.

American family physician, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.